Welcome to Medications.com

FDA Approves Wyeth's New Antidepressant Pristiq, Planned Successor ... - Trading Markets (press release)

Effexor XR, Wyeth's extended-release depression drug, last year posted $3.8 billion, 17 percent of its total revenue. Cheaper generic competition is ...

http://www.tradingmarkets.com/.si... | Posted: Sun Mar 02 23:00:10 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea